Ekso Bionics Holdings, Inc.

EKSO - Financial Snapshot

Healthcare sector | Medical Instruments & Supplies industry

View on:
Ranks:

Metrics for EKSO

Price $9.07
Shares Outstanding 3.56M
All-Time Low $2.73
52-Week Low $2.73

Balance Statement Metrics

Net Cash / Share $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
Net Current Assets / Share $0.79
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
Net Tangible Assets / Share $1.43
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
Shares Outstanding Ave Change (Annual) 20.49%
Shares Δ YoY 49.54%

Income Metrics

Max Earning Power / Share $-2.77
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
Adjusted Earning Power $-3.8
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
Non-Cash Charges to Market Cap 1.18%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Data as of: Price 02-03-26 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Pays Dividend No 2-1-2026
Last Dividend Date 3-24-20
Income indicators Value Date
EBITDA Positive No 2-1-2026
Net Income Positive No 2-1-2026
Avg CA Burn (Annual %) -25.57% 2-1-2026
Avg CA Burn (Quarterly %) -7.96% 2-1-2026

Shares Outstanding Changes

Date Shares Outstanding Delta
2026-01-26 3,563,152 +170,429
2026-01-22 3,392,723 +769,490
2025-10-31 2,623,233 +11,445
2025-09-19 2,611,788 -2
2025-08-04 2,611,790 +245,120

Short Interest Changes

Latest short interest: 305,750 shares (9.14% of float) | Days to cover: 0.05

Date Short Interest Delta Δ %
2026-02-03 305,750 shares +0 +0.00%
2026-02-02 305,750 shares +0 +0.00%
2026-01-30 305,750 shares None —

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date Volume Shares Outstanding Volume / Shares Price
2026-01-06 960,537 2,623,233 36.62% $9.53
2026-01-05 762,306 2,623,233 29.06% $8.55
2026-01-02 1,203,228 2,623,233 45.87% $7.84
2025-12-31 3,662,015 2,623,233 139.60% $8.64
2025-12-30 109,228,442 2,623,233 4163.89% $10.58

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EVO, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. It also offers EksoCare offering an extended warranty and premium service options, repairs and maintenance services, and training programs. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.